Randomized Comparison of Warfarin Dosing Quality Between the Hamilton Nomogram and a Commercial Computer System
NCT01024452 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1298
Last updated 2011-07-20
Summary
Randomized comparison of warfarin dosing quality between the Hamilton nomogram and a commercial computer system.
Hypothesis: Mean TTR of patients managed with the commercial computer system is non-inferior to management with the validated Hamilton Nomogram.
Conditions
- Patients at Risk for Thrombosis
Interventions
- DEVICE
-
DAWN AC
computerized dosing management system for anticoagulation clinics
- DEVICE
-
Hamilton Nomogram
simple nomogram for warfarin maintenance dosing
Sponsors & Collaborators
-
Population Health Research Institute
lead OTHER
Principal Investigators
-
Stuart Connolly, MD · Director, Division of Cardiology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Effectiveness of NextDose for Warfarin Dose Individualization
NCT04510805 ·Status: UNKNOWN ·Phase: PHASE4
-
Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients
NCT01401725 ·Status: COMPLETED ·Phase: NA
-
Early Identification of Warfarin Maintenance Dosage
NCT01178034 ·Status: COMPLETED ·Phase: PHASE3
-
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
NCT01348074 ·Status: COMPLETED ·Phase: PHASE2
-
Warfarin Initiation in Mechanical Mitral Valve Replacement Patients
NCT04235569 ·Status: COMPLETED ·Phase: PHASE4
-
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
NCT00401414 ·Status: COMPLETED ·Phase: NA
-
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 ·Status: COMPLETED ·Phase: PHASE2
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation
NCT02094157 ·Status: TERMINATED ·Phase: PHASE3
-
Reinforcement Learning for Warfarin Dosing
NCT03962400 ·Status: WITHDRAWN ·Phase: PHASE4
-
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
NCT00993200 ·Status: COMPLETED ·Phase: PHASE4
-
The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.
NCT02710747 ·Status: UNKNOWN ·Phase: PHASE4
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
NCT00830570 ·Status: COMPLETED
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
A Prospective Cohort Study on Warfarin Personalized Medication
NCT06428110 ·Status: COMPLETED
-
Personalized Warfarin Dosing by Genomics and Computational Intelligence
NCT00872079 ·Status: TERMINATED ·Phase: NA
-
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
NCT00634907 ·Status: COMPLETED ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Fearon Algorithm in Warfarin Patient Self-Management
NCT03911661 ·Status: COMPLETED ·Phase: NA
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725 ·Status: COMPLETED
-
Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
NCT01124058 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4